Company or ticker...

Protagonist Therapeutics

Protagonist develops peptide-based medicines for immune, blood, and inflammatory diseases.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

PTGX

9.2B

33.9

136.8

63.92%

Key Facts

M. Cap

PS

PE

YTD

9.2B

33.9

136.8

63.92%

10MA

20MA

50MA

200MA

$PTGX